Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.

Miller CH, Benson J, Ellingsen D, Driggers J, Payne A, Kelly FM, Soucie JM, Craig Hooper W; Hemophilia Inhibitor Research Study Investigators..

Haemophilia. 2012 May;18(3):375-82. doi: 10.1111/j.1365-2516.2011.02700.x. Epub 2011 Nov 21.

PMID:
22103590
2.

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.

Gouw SC, Van Der Bom JG, Van Den Berg HM, Zewald RA, Ploos Van Amstel JK, Mauser-Bunschoten EP.

Haemophilia. 2011 Mar;17(2):275-81. doi: 10.1111/j.1365-2516.2010.02420.x. Epub 2010 Nov 11.

PMID:
21070499
3.

Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients.

Lochan A, Macaulay S, Chen WC, Mahlangu JN, Krause A.

Haemophilia. 2014 Sep;20(5):687-92. doi: 10.1111/hae.12436. Epub 2014 Jun 21.

PMID:
24953131
4.

The Canadian "National Program for hemophilia mutation testing" database: a ten-year review.

Rydz N, Leggo J, Tinlin S, James P, Lillicrap D.

Am J Hematol. 2013 Dec;88(12):1030-4. doi: 10.1002/ajh.23557. Epub 2013 Sep 9. Review. Erratum in: Am J Hematol. 2014 Jun;89(6):669. Natalia, Rydz [corrected to Rydz, Natalia]; Jayne, Leggo [corrected to Leggo, Jayne]; Shawn, Tinlin [corrected to Tinlin, Shawn]; Paula, James [corrected to James, Paula]; David, Lillicrap [corrected to Lillicrap, David].

5.

Mutation spectrum and inhibitor risk in 100 Korean patients with severe haemophilia A.

Kim HJ, Chung HS, Kim SK, Yoo KY, Jung SY, Park IA, Lee KO, Kim SH, Kim HJ.

Haemophilia. 2012 Nov;18(6):1008-13. doi: 10.1111/j.1365-2516.2012.02895.x. Epub 2012 Jun 29.

PMID:
22741565
6.

Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing.

Lyu C, Xue F, Liu X, Liu W, Fu R, Sun T, Wu R, Zhang L, Li H, Zhang D, Yang R, Zhang L.

Haemophilia. 2016 Sep;22(5):e427-34. doi: 10.1111/hae.12924. Epub 2016 Jun 13.

PMID:
27292088
7.

The correlation between gene mutations and inhibitor development in patients with haemophilia A in southern Iran.

Haghpanah S, Sahraiian M, Afrasiabi A, Enayati S, Peyvandi F, Karimi M.

Haemophilia. 2011 Sep;17(5):820-1. doi: 10.1111/j.1365-2516.2011.02510.x. Epub 2011 Mar 4. No abstract available.

PMID:
21371201
8.

Study of mutations in Jordanian patients with haemophilia A: identification of five novel mutations.

Awidi A, Ramahi M, Alhattab D, Mefleh R, Dweiri M, Bsoul N, Magablah A, Arafat E, Barqawi M, Bishtawi M, Haddadeen E, Falah M, Tarawneh B, Swaidan S, Fauori S.

Haemophilia. 2010 Jan;16(1):136-42. doi: 10.1111/j.1365-2516.2009.02081.x. Epub 2009 Oct 7.

PMID:
19817879
9.

Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.

Boekhorst J, Lari GR, D'Oiron R, Costa JM, Nováková IR, Ala FA, Lavergne JM, VAN Heerde WL.

Haemophilia. 2008 Jul;14(4):729-35. doi: 10.1111/j.1365-2516.2008.01694.x. Epub 2008 May 12.

PMID:
18503540
10.

F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors.

Salviato R, Belvini D, Radossi P, Sartori R, Pierobon F, Zanotto D, Zanon E, Castaman G, Gandini G, Tagariello G.

Haemophilia. 2007 Jul;13(4):361-72.

PMID:
17610549
11.

A possible mechanism for Inv22-related F8 large deletions in severe hemophilia A patients with high responding factor VIII inhibitors.

Fujita J, Miyawaki Y, Suzuki A, Maki A, Okuyama E, Murata M, Takagi A, Murate T, Suzuki N, Matsushita T, Saito H, Kojima T.

J Thromb Haemost. 2012 Oct;10(10):2099-107. doi: 10.1111/j.1538-7836.2012.04897.x.

12.

Identification of seven novel mutations in the factor VIII gene in 18 unrelated Chinese patients with hemophilia A.

Hua BL, Yan ZY, Liang Y, Yan M, Fan LK, Li KX, Xiao B, Liu JZ, Zhao YQ.

Chin Med J (Engl). 2010 Feb 5;123(3):305-10.

PMID:
20193250
13.

Molecular analysis of F8 in Lebanese haemophilia A patients: novel mutations and phenotype-genotype correlation.

Djambas Khayat C, Salem N, Chouery E, Corbani S, Moix I, Nicolas E, Morris MA, de Moerloose P, Mégarbané A.

Haemophilia. 2008 Jul;14(4):709-16. doi: 10.1111/j.1365-2516.2008.01760.x. Epub 2008 May 7.

PMID:
18479430
14.

F8 and F9 mutations fail to co-segregate in a family with co-incident haemophilia A and B.

Siddiq S, Morse C, Goodeve A, Panayi M, Tait RC, Mumford A.

Haemophilia. 2011 Jan;17(1):e230-4. doi: 10.1111/j.1365-2516.2010.02396.x. Epub 2010 Sep 22.

PMID:
20860608
15.

Risk factors associated with inhibitor development in Chinese patients with haemophilia B.

Zhou J, Ding Q, Chen Z, Yang H, Lin L, Wang H, Wang X, Wu R.

Haemophilia. 2015 Jul;21(4):e286-93. doi: 10.1111/hae.12684. Epub 2015 Apr 30.

PMID:
25929987
16.

A large-scale computational study of inhibitor risk in non-severe haemophilia A.

Shepherd AJ, Skelton S, Sansom CE, Gomez K, Moss DS, Hart DP.

Br J Haematol. 2015 Feb;168(3):413-20. doi: 10.1111/bjh.13131. Epub 2014 Sep 22.

PMID:
25244644
17.

A genetic view on the etiology of the inhibitor complication.

Giannelli F, Green PM, Naylor JA.

Blood. 1996 Mar 15;87(6):2612. No abstract available.

18.

Frequency of intron 1 and 22 inversions of Factor VIII gene in Mexican patients with severe hemophilia A.

Mantilla-Capacho JM, Beltrán-Miranda CP, Luna-Záizar H, Aguilar-López L, Esparza-Flores MA, López-Guido B, Troyo-Sanromán R, Jaloma-Cruz AR.

Am J Hematol. 2007 Apr;82(4):283-7.

19.

Genetic risk factors for inhibitors to factors VIII and IX.

Oldenburg J, Pavlova A.

Haemophilia. 2006 Dec;12 Suppl 6:15-22. Review.

PMID:
17123389
20.

Inhibitors in the Swedish population with severe haemophilia A and B: a 20-year survey.

Knobe KE, Sjörin E, Tengborn LI, Petrini P, Ljung RC.

Acta Paediatr. 2002;91(8):910-4.

PMID:
12222714

Supplemental Content

Support Center